natgillin/translations-raw huggingface dataset:
• Severe hypoglycaemic episodes, where the patient has become unconscious, can be treated with glucagon (0.5 to 1 mg) given intramuscularly or subcutaneously by a trained person, or with glucose given intravenously by physicians or other healthcare staff.
• Hude hipoglikemije, ko je bolnik nezavesten, je mogoče zdraviti z glukagonom (0,5 do 1 mg), ki ga intramuskularno ali subkutano aplicira ustrezno podučena oseba, ali z glukozo, ki jo intravensko aplicira zdravnik ali drugo zdravstveno osebje.
► When symptoms of low blood sugar have disappeared or when blood sugar level is stabilised, continue insulin treatment as usual.
► Ko simptomi nizkega krvnega sladkorja izginejo ali se koncentracija sladkorja v krvi stabilizira, nadaljujte zdravljenje z insulinom kot ponavadi.
The pharmacodynamic profile of insulin aspart in children was similar to that seen in adults.
Farmakodinamični profil insulina aspart pri otrocih je bil podoben kot pri odraslih.
• Growth hormone (medicine for stimulation of skeletal and somatic growth and pronounced influence on the body's metabolic processes)
• rastni hormon (zdravilo za spodbuditev skeletne in somatske rasti ter z izrazitim vplivom na telesna presnovna dogajanja),
Make sure you can see the dose counter.
Prepričajte se, da lahko vidite števec odmerka.
► If you are treated with NovoRapid Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin.
► Če se zdravite z zdravilom NovoRapid Penfill in še drugim insulinom v vložkih Penfill, morate uporabljati dva sistema za dajanje insulina, enega za vsako vrsto insulina.
• Check the expiry date, which is stated on the label and the carton.
• Preverite datum izteka roka uporabnosti, ki je naveden na nalepki in na škatli.
Since NovoRapid should be administered in immediate relation to a meal, the rapid onset of action should be considered in patients with concomitant diseases or treatment where a delayed absorption of food might be expected.
Ker je treba zdravilo NovoRapid aplicirati neposredno ob obroku, je treba hiter začetek delovanja upoštevati pri bolnikih, pri katerih je mogoče zaradi spremljajočih bolezni ali zdravljenja pričakovati upočasnjeno absorpcijo hrane.
Painful neuropathy (pain due to nerve damage): If your blood sugar level improves very fast, you may get nerve related pain.
Boleča nevropatija (bolečina zaradi okvare živca): če se vam koncentracija sladkorja v krvi izboljša zelo hitro, lahko doživite z živci povezane bolečine.
NovoRapid Vial, InnoLet, FlexTouch and PumpCart:
NovoRapid viala, InnoLet, FlexTouch in PumpCart:
If you have reduced kidney or liver function, or if you are above 65 years of age, you need to check your blood sugar more regularly and discuss changes in your insulin dose with your doctor.
Če imate zmanjšano delovanje ledvic ali jeter ali če ste starejši od 65 let, si morate krvni sladkor meriti bolj redno, o spremembah odmerka insulina pa se morate posvetovati s svojim zdravnikom.
NovoRapid vial/NovoRapid Penfill
NovoRapid viala/NovoRapid Penfill
Although stable over time, a certain amount of insulin will be initially adsorbed to the material of the infusion bag.
Kljub časovni stabilnosti se določena količina insulina spočetka adsorbira na material infuzijske vrečke.
However, the NovoRapid dose may need to be adjusted.
Potrebna pa utegne biti prilagoditev odmerka zdravila NovoRapid.
Swollen joints: When you start taking insulin, water retention may cause swelling around your ankles and other joints.
Otekli sklepi: ko začnete uporabljati insulin, lahko zastajanje vode povzroči otekline okrog gležnjev in drugih sklepov.
For use in an infusion pump system
Za uporabo v infuzijskem sistemu s črpalko
Before travelling between different time zones, the patient should seek the doctor's advice since this may mean that the patient has to take the insulin and meals at different times.
Pred potovanjem med različnimi časovnimi pasovi se mora bolnik posvetovati z zdravnikom, kajti morda bo moral zaradi tega injicirati insulin in uživati obroke ob drugačnih časih.
Especially in children, care should be taken to match insulin doses (especially in basal-bolus regimens) with food intake, physical activities and current blood glucose level in order to minimise the risk of hypoglycaemia.
Še posebej pri otrocih je treba poskrbeti, da odmerki insulina (še posebej pri bazalno-bolusnih shemah zdravljenja) ustrezajo vnosu hrane, telesni dejavnosti in trenutni koncentraciji glukoze v krvi, tako da se zmanjša tveganje za pojav hipoglikemije.
The frequencies of hypoglycaemia vary with patient population, dose regimens and level of glycaemic control (see section 4.8, Description of selected adverse reactions).
Pogostnost hipoglikemij se razlikuje med populacijami bolnikov, odmernimi shemami in ravnjo urejenosti glikemije (glejte poglavje 4.8, podpoglavje Opis izbranih neželenih učinkov).
Some medicines affect your blood sugar level and this may mean that your insulin dose has to change.
Nekatera zdravila vplivajo na koncentracijo krvnega sladkorja, kar lahko pomeni, da boste morali spremeniti odmerek insulina.
What you need to know before you use NovoRapid PumpCart Do not use NovoRapid PumpCart ► If you are allergic to insulin aspart, or any of the other ingredients in this medicine (see section 6, Contents of the pack and other information).
Kaj morate vedeti, preden boste uporabili zdravilo NovoRapid PumpCart Ne uporabljajte zdravila NovoRapid PumpCart: ► če ste alergični na insulin aspart ali katero koli drugo sestavino tega zdravila (glejte poglavje 6, Vsebina pakiranja in dodatne informacije),
• If the second and third characters are S6, P5, K7, R7, VG, FG or ZF, the manufacturer is Novo Nordisk A/S, Novo Allé, DK-2880 Bagsværd, Denmark.
• Če sta drugi in tretji znak S6, P5, K7, R7, VG, FG ali ZF, je izdelovalec Novo Nordisk A/S, Novo Allé, DK-2880 Bagsvaerd, Danska.
This may reduce the risk of developing lumps or skin pitting (see section 4, Possible side effects).
To lahko zmanjša tveganje za nastanek zatrdlin ali ugreznjenosti kože (glejte poglavje 4, Možni neželeni učinki).
• Sulphonamides (used to treat infections).
• sulfonamide (uporabljajo se za zdravljenje okužb).
a) Summary of serious and very common side effects Low blood sugar (hypoglycaemia) is a very common side effect.
a) Povzetek resnih in zelo pogostih neželenih učinkov Nizek krvni sladkor (hipoglikemija) je zelo pogost neželeni učinek.
• Drink alcohol (see Drinking alcohol and taking NovoRapid in section 2).
• pijete alkohol (glejte poglavje 2, podpoglavje Zdravilo NovoRapid skupaj z alkoholom).
Insulin aspart was rapidly absorbed in both age groups, with similar tmax as in adults.
V obeh starostnih skupinah se je insulin aspart hitro absorbiral; tmax je bil podoben kot pri odraslih.
Diabetic retinopathy (an eye disease related to diabetes which can lead to loss of vision): If you have diabetic retinopathy and your blood sugar level improves very fast, the retinopathy may get worse.
Diabetična retinopatija (s sladkorno boleznijo povezana bolezen oči, ki lahko povzroči izgubo vida): če imate diabetično retinopatijo in se vam koncentracija sladkorja v krvi zelo hitro izboljša, se lahko retinopatija poslabša.
• Screw the needle straight and tightly onto your InnoLet (picture 1A).
• Iglo naravnost in trdno privijte na injekcijski peresnik InnoLet (slika 1A)
NovoRapid (insulin aspart) can be used in pregnancy.
Zdravilo NovoRapid (insulin aspart) se lahko uporablja med nosečnostjo.
When the pen contains less than 80 units, the dose counter stops at the number of units left.
Ko je v injekcijskem peresniku preostalo manj kot 80 enot, se števec odmerka ustavi pri številu preostalih enot.
Frequency categories are defined according to the following convention: Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100);
Skupine pogostnosti so opredeljene po naslednjem dogovoru: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
CSII should be administered in the abdominal wall.
CSII je treba aplicirati v trebušno steno.
Tubings in which the inner surface materials are made of polyethylene or polyolefin have been evaluated and found compatible with pump use.
Sistemi (cevke), v katerih je material na notranji površini iz polietilena ali poliolefina, so bili ocenjeni in ugotovljeno je bilo, da so kompatibilni z uporabo črpalke.
• Sympathomimetics (such as epinephrine [adrenaline], or salbutamol, terbutaline used to treat asthma)
• simpatikomimetike (na primer adrenalin, salbutamol ali terbutalin, uporabljajo se za zdravljenje astme),
What you need to know before you use NovoRapid
Kaj morate vedeti, preden boste uporabili zdravilo NovoRapid
Normally you will inject your insulin in the front of your waist (abdomen).
Ponavadi boste insulin injicirali v sprednji del pasu (trebuh).
Your InnoLet is designed to work accurately and safely.
Vaš injekcijski peresnik InnoLet je izdelan za natančno in varno delovanje.
If no drop appears, repeat steps F to H up to 6 times.
Če se kapljica insulina ne pojavi, ponovite korake F do H največ šestkrat.
Always use your insulin and adjust your dose exactly as your doctor has told you.
Insulin vedno uporabite in prilagajajte odmerek tako, kot vam je to naročil vaš zdravnik.
If no drop appears after these new attempts, change the needle and repeat steps F to H once more.
Če tudi po šestih poskusih še ne vidite kapljice, zamenjajte iglo in ponovite korake F do H še enkrat.
• If the second and third characters are H7 or T6, the manufacturer is Novo Nordisk Production SAS, 45 Avenue d'Orléans F-28000 Chartres, France.
• Če sta drugi in tretji znak H7 ali T6, je izdelovalec Novo Nordisk Production SAS, 45 Avenue d'Orléans F-28000 Chartres, Francija.
Diabetes is a disease where your body does not produce enough insulin to control the level of your blood sugar.
Sladkorna bolezen je bolezen, pri kateri v telesu ne nastaja dovolj insulina, da bi uravnal koncentracijo krvnega sladkorja.
For intravenous use, infusion systems with NovoRapid 100 units/ml at concentrations from 0.05 unit/ml to 1.0 unit/ml insulin aspart in the infusion fluids 0.9% sodium chloride, 5% dextrose or 10% dextrose including 40 mmol/l potassium chloride using polypropylene infusion bags, are stable at room temperature for 24 hours.
Infuzijski sistemi za intravensko infundiranje z zdravilom NovoRapid 100 enot/ml v koncentraciji od 0,05 do 1,0 enote/ml insulina aspart v infuzijskih tekočinah 0,9 % raztopine natrijevega klorida, 5 % raztopine glukoze ali 10 % raztopine glukoze, vključno s 40 mmol/l raztopine kalijevega klorida, z uporabo polipropilenskih infuzijskih vrečk so pri sobni temperaturi stabilni 24 ur.
Just before use, roll the NPH insulin between your hands until the liquid is uniformly white and cloudy.
Insulin NPH tik pred uporabo zavrtite med dlanmi, dokler ni tekočina enakomerno bela in motna.
Always mix NovoRapid and the NPH insulin in the same sequence.
Zdravilo NovoRapid in insulin NPH vedno zmešajte v istem zaporedju.
Concomitant illness, especially infections and feverish conditions, usually increases the patient's insulin requirements.
Spremljajoče bolezni, posebno okužbe in stanja z zvišano telesno temperaturo, ponavadi zvečajo bolnikovo potrebo po insulinu.
NovoRapid can be used in children and adolescents aged 1 year and above in preference to soluble human insulin when a rapid onset of action might be beneficial, for example, in the timing of the injections in relation to meals (see sections 5.1 and 5.2).
Pri mladostnikih in otrocih, starih 1 leto in več, ima zdravilo NovoRapid prednost pred topnim humanim insulinom, če bi bil hiter začetek delovanja lahko koristen, npr. pri časovnem usklajevanju injekcij glede na obroke (glejte poglavji 5.1 in 5.2).
Patients with renal failure necessitating dialysis treatment were not investigated.
Farmakokinetike pri bolnikih z odpovedjo ledvic, ki potrebujejo zdravljenje z dializo, niso raziskali.
EXP/ During use: Use within 4 weeks
EXP/ Med uporabo: porabite v 4 tednih.
To get the benefit of insulin infusion, and to detect possible malfunction of the insulin pump, it is recommended that you measure your blood sugar level regularly.
Da vam bo infuzija insulina koristila in da boste odkrili morebitno nepravilno delovanje insulinske črpalke, si morate redno meriti krvni sladkor.
When transferring from other insulin medicinal products, adjustment of the NovoRapid dose and the dose of the basal insulin may be necessary.
Pri prehodu z drugih insulinskih zdravil je lahko potrebna prilagoditev odmerka zdravila NovoRapid in odmerka bazalnega insulina.
How to use NovoRapid PumpCart Dose and when to take your insulin
Kako uporabljati zdravilo NovoRapid PumpCart Odmerek in kdaj uporabiti insulin
What to do if you experience high blood sugar: ► If you get any of the above signs: test your blood sugar level, test your urine for ketones if you can, then seek medical advice immediately.
Kaj storiti, če se vam pojavi visok krvni sladkor ► Če se vam pojavi kateri od zgoraj omenjenih znakov, si izmerite sladkor v krvi, določite ketone v urinu, če imate to možnost, potem pa takoj poiščite zdravniški nasvet.
► If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Nosečnost in dojenje ► Če ste noseči, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte s svojim zdravnikom, preden boste uporabili to zdravilo.
If you use only one type of insulin
Če uporabljate samo eno vrsto insulina
If you change the basal insulin setting the change will start to affect you within 10-20 minutes.
Če spremenite nastavitve za bazalni insulin, boste spremembo občutili po 10 do 20 minutah.
The efficacy and safety of NovoRapid given as bolus insulin in combination with either insulin detemir or insulin degludec as basal insulin has been studied for up to 12 months, in two randomised controlled clinical trials in adolescents and children aged 1 to less than 18 years (n=712).
Učinkovitost in varnost zdravila NovoRapid, uporabljenega kot bolusni insulin v kombinaciji z insulinom detemir ali insulinom degludek kot bazalnim insulinom, so v obdobju do 12 mesecev proučevali v dveh randomiziranih, kontroliranih kliničnih preskušanjih pri mladostnikih in otrocih, starih od 1 do manj kot 18 let (n = 712).
Make sure that you receive your full dose by using the right injection technique.
Prepričajte se, da injicirate celoten odmerek z uporabo pravilnega postopka injiciranja.
The occurrence of generalised hypersensitivity reactions (including generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation and reduction in blood pressure) is very rare but can potentially be life threatening.
Pojav generaliziranih preobčutljivostnih reakcij (med drugim generalizirani izpuščaj na koži, srbenje, znojenje, prebavne motnje, angionevrotični edem, težave pri dihanju, palpitacije in znižanje krvnega tlaka) je zelo redek, vendar je lahko smrtno nevaren.
It is best to measure your blood sugar level regularly to get the maximum benefit of insulin delivery, and to make sure the pump is working properly.
Najbolje je, da si redno merite koncentracijo sladkorja v krvi; tako boste imeli od dajanja insulina največ koristi in se boste prepričali, da črpalka deluje pravilno.
Data from two randomised controlled clinical trials (322 and 27 exposed pregnancies) do not indicate any adverse effect of insulin aspart on pregnancy or on the health of the foetus/newborn when compared to human insulin (see section 5.1).
Podatki dveh randomiziranih, kontroliranih kliničnih preskušanj (322 in 27 izpostavljenih nosečnosti) ne kažejo neželenih učinkov insulina aspart na nosečnost ali na zdravje ploda/novorojenčka v primerjavi s humanim insulinom (glejte poglavje 5.1).
Removing the needle
Odstranitev igle
If necessary NovoRapid can be given directly into a vein but this must only be done by physicians or other healthcare staff.
Če je treba, je mogoče zdravilo NovoRapid injicirati neposredno v veno, vendar sme to narediti le zdravnik ali drugo zdravstveno osebje.
The pharmacokinetic and pharmacodynamic properties of NovoRapid were investigated in children (6-12 years) and adolescents (13-17 years) with type 1 diabetes.
Farmakokinetične in farmakodinamične lastnosti zdravila NovoRapid so raziskali pri otrocih (612 let) in mladostnikih (13-17 let) s sladkorno boleznijo tipa 1.
When the pen is empty, throw it away without a needle on as instructed by your doctor, nurse or local authorities.
Ko je peresnik prazen, ga pazljivo zavrzite brez nameščene igle, kot vam je to naročil vaš zdravnik ali medicinska sestra, v skladu z lokalnimi predpisi.
Dose and when to take your insulin
Odmerek in kdaj uporabiti insulin
The time to maximum concentration is, on average, half of that for soluble human insulin.
Čas do največje koncentracije je v povprečju pol krajši kot pri topnem humanem insulinu.
Substances added to NovoRapid may cause degradation of insulin aspart.
Dodajanje snovi zdravilu NovoRapid bi lahko povzročilo razgradnjo insulina aspart.
Component of a multipack, cannot be sold separately.
Škatla je del skupnega pakiranja in se je ne sme izdajati posamično.
Uncommon - Urticaria, rash, eruptions Very rare - Anaphylactic reactions*
Bolezni imunskega sistema Občasni - urtikarija, izpuščaj, erupcije Zelo redki - anafilaktične reakcije*
If you take more insulin than you should
Če ste uporabili večji odmerek insulina, kot bi smeli
A number of medicinal products are known to interact with the glucose metabolism.
Za številna zdravila je znano, da vplivajo na presnovo glukoze.
What NovoRapid is and what it is used for
Kaj je zdravilo NovoRapid in za kaj ga uporabljamo
See c) Effects from diabetes in section 4.
Glejte poglavje 4, podpoglavje c) Učinki zaradi sladkorne bolezni.
AUC, Cmax and CL/F were similar in patients with reduced hepatic function compared with subjects with normal hepatic function.
AUC, Cmax in očistek (CL/F) so bili pri bolnikih z zmanjšanim delovanjem jeter podobni tistim pri preiskovancih z normalnim delovanjem jeter.
This is normal and has no effect on the dose you just received.
To je normalno in ne vpliva na injicirani odmerek.
Before you set or change the basal rate, carefully read the pump manual (user guide).
Pred nastavitvijo ali spreminjanjem hitrosti dajanja insulina za bazalne potrebe natančno preberite navodila za uporabo črpalke (vodnik za uporabnika).
Keep the push-button fully depressed and let the needle remain under the skin for at least 6 seconds.
Držite potisni gumb povsem pritisnjen in pustite iglo pod kožo vsaj 6 sekund.
Patients transferred to NovoRapid from another type of insulin may require an increased number of daily injections or a change in dose from that used with their usual insulin medicinal products.
Bolniki, ki preidejo na zdravilo NovoRapid z druge vrste insulina, utegnejo potrebovati večje število dnevnih injekcij ali drugačen odmerek kot med uporabo svojih običajnih insulinskih zdravil.
In NovoRapid substitution of amino acid proline with aspartic acid at position B28 reduces the tendency to form hexamers as observed with soluble human insulin.
Substitucija aminokisline prolina z asparaginsko kislino na položaju B28 v zdravilu NovoRapid zmanjša nagnjenost k tvorbi heksamer, ki je opazna pri topnem humanem insulinu.
• Follow the steps described in section 1 and 2 to prepare and insert a new NovoRapid PumpCart into your pump.
• Sledite korakom, opisanim v poglavju 1 in 2, da boste pripravili nov vložek NovoRapid PumpCart in ga vstavili v insulinsko črpalko.
Bolus (meal-time) insulin requirements: NovoRapid will start to lower your blood sugar within 1020 minutes after you start a bolus delivery (see section 3, How to use NovoRapid PumpCart, for more information about how to adjust your bolus dose).
Bolusne potrebe po insulinu (potrebe ob obrokih): Zdravilo NovoRapid vam bo začelo zniževati krvni sladkor v 10 do 20 minutah po začetku bolusnega dajanja (za več informacij o prilagajanju bolusnega odmerka glejte poglavje 3, Kako uporabljati zdravilo NovoRapid PumpCart).
If your blood sugar is low or high, your concentration and ability to react might be affected and therefore also your ability to drive or operate a machine. Bear in mind that you could endanger yourself or others.
Če imate visok ali nizek krvni sladkor, se vam zbranost in sposobnost reagiranja lahko spremenita, s tem pa tudi vaša sposobnost za upravljanje vozil in strojev.
► If you have such a low blood sugar that it makes you pass out, if you have had need for injection of glucagon, or if you have experienced many incidents of low blood sugar, talk with a doctor.
► Če imate tako nizek krvni sladkor, da se onesvestite, če ste morali dobiti injekcijo glukagona ali če ste velikokrat imeli nizek krvni sladkor, se posvetujte z zdravnikom.
The insulin will work more quickly if injected into the front of your waist.
Insulin bo začel delovati hitreje, če si ga injicirate v sprednji del trebuha.
Your bolus (meal-time) insulin needs to be adjusted based on your blood sugar measurement and food intake.
Bolusne odmerke insulina (odmerke ob obrokih) morate prilagoditi glede na izmerjeni krvni sladkor in uživanje hrane.
► Keep the needle under your skin for at least 6 seconds to make sure you have injected all the insulin.
► Igla naj ostane pod kožo vsaj 6 sekund; tako boste zagotovili injiciranje vsega insulina.
b) List of other side effects
b) Seznam drugih neželenih učinkov
Octreotide/lanreotide may either increase or decrease the insulin requirement.
Oktreotid/lanreotid lahko potrebo po insulinu zveča ali zmanjša.
The absorption rate was somewhat slower in type 2 diabetic patients, resulting in a lower Cmax (352±240 pmol/l) and later tmax (60 (interquartile range: 50-90) minutes).
Pri bolnikih s sladkorno boleznijo tipa 2 je bila hitrost absorpcije nekoliko počasnejša, zato je bila Cmax manjša (352 ± 240 pmol/l), tmax pa poznejši (60 (interkvartilni razpon: 50-90) minut).
Use the injection technique advised by your doctor or nurse and as described in your pen manual.
Za injiciranje uporabite postopek, ki vam ga je svetoval zdravnik ali medicinska sestra in kot je opisan v priročniku vašega injekcijskega peresnika.
METHOD AND ROUTES OF ADMINISTRATION Needles are not included
POSTOPEK IN POTI UPORABE ZDRAVILA Igle niso priložene.
NovoRapid may be used in an infusion pump system (CSII) as described in section 4.2.
Zdravilo NovoRapid se lahko uporablja v infuzijskem sistemu s črpalko (CSII), kot je opisano v poglavju 4.2.
High blood sugar (hyperglycaemia)
Visok krvni sladkor (hiperglikemija)
NovoRapid must be protected from excessive heat and light.
Zdravilo NovoRapid je treba zaščititi pred čezmerno toploto in svetlobo.
• Dispose of the empty NovoRapid PumpCart cartridge and the used infusion set as instructed by your doctor or nurse.
• Zavrzite prazni vložek NovoRapid PumpCart ter uporabljeni komplet za infundiranje, kot vam je naročil zdravnik ali medicinska sestra.
You can carry it with you and keep it at room temperature (below 30°C) for up to 4 weeks.
S seboj ga lahko nosite in shranjujete pri sobni temperaturi (do 30 °C) do 4 tedne.
If you experience any problems contact your doctor.
Če se vam pojavijo kakšne težave, se posvetujte z zdravnikom.
Patients whose blood glucose control is greatly improved, e.g. by intensified insulin therapy, may experience a change in their usual warning symptoms of hypoglycaemia, and should be advised accordingly.
Bolnikom, ki se jim uravnanost glukoze v krvi zelo izboljša, npr. z intenziviranim insulinskim zdravljenjem, se običajni opozorilni simptomi hipoglikemije lahko spremenijo in jih je s to možnostjo treba seznaniti.
NovoRapid will start to lower your blood sugar 10-20 minutes after you inject it, a maximum effect occurs between 1 and 3 hours after the injection and the effect lasts for 3-5 hours.
Zdravilo NovoRapid začne sladkor v krvi zniževati v 10 do 20 minutah po uporabi, doseže največji učinek v 1 do 3 urah po injiciranju in deluje od 3 do 5 ur.